“Long-Term Safety and Disease Control With Ruxolitinib Cream Among Patients With Atopic Dermatitis Based on Previous Medication History: Pooled Results from Two Phase 3 Studies”. 2021. SKIN The Journal of Cutaneous Medicine 5 (6): s65. https://doi.org/10.25251/skin.5.supp.65.